Aberdeen Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9M | Sell |
391,600
-15,100
| -4% | -$806K | 0.04% | 398 |
|
|
2025
Q1 | $16.5M | Buy |
406,700
+136,918
| +51% | +$5.54M | 0.03% | 438 |
|
|
2024
Q4 | $7.51M | Buy |
269,782
+146,424
| +119% | +$4.07M | 0.01% | 564 |
|
|
2024
Q3 | $3.54M | Sell |
123,358
-75,879
| -38% | -$2.18M | 0.01% | 703 |
|
|
2024
Q2 | $4.67M | Hold |
199,237
| – | – | 0.01% | 638 |
|
|
2024
Q1 | $5.03M | Buy |
199,237
+127,695
| +178% | +$3.23M | 0.01% | 666 |
|
|
2023
Q4 | $1.67M | Buy |
+71,542
| New | +$1.67M | ﹤0.01% | 787 |
|